the insulin receptor of human monocytes is more sensitive to regulation by ambient insulin than the receptors of obese mice and cultured human lymphocytes. The results further indicate that an insulin receptor undergoes in vivo modulation of its interaction with insulin by changing receptor concentration and by altering the affinity of existing receptors.
A B S T RA C T The binding of 125I-insulin to insulin receptors on circulating monocytes of obese patients and normal volunteers has been determined under various dietary states. In the basal, fed state the monocytes of obese patients with clinical insulin resistance (n = 6) bound less insulin than normals (n = 10) because of a decrease in insulin receptor concentration (obese = 6,000-13,000 sites per monocyte versus nornals 15,000-28,000 sites per monocyte). The single obese patient without evidence of clinical insulin resistance demonstrated normal binding of insulin with 16,000 sites per monocyte. In all patients, the total receptor concentration was inversely related to the circulating levels of insulin measured at rest after an overnight fast.
For the obese patients with basally depressed insuilin binding, a 48-72-h fast lowered circtulating insulin and increased binding to normal levels but only at low hormone concentrations; this limited normalization of 125I-insulin binding was associated with increased receptor affinity for insulin without change in receptor concentration. Refeeding after the acute fasting periods resulted in return to the elevated plasma insulin levels, the basal receptor affinity, and the depressed instulin binding observed in the basal, fed state. Chronic diet restored plasma insulin levels, insulin binding, and receptor concentration to normal without change in affinity.
When the data from this study are coupled with prevous in vivo and in vitro findings they suggest that INTRODUCTION Obesity is commonly associated with hyperinsulinemia and resistance to the action of endogenous and exogenous insulin (1, 2) . In both genetic and acquired forms of obesity in rodents, the increased concentrations of circulating insulin are associated with decreased insulin binding to liver (3) (4) (5) (6) , muscle (7) , fat (8) (9) (10) , and thymus lymphocytes (11, 12) . The decrease in insulin binding is due entirely to a decreased concentration of insulin receptors; these residual receptors are normal receptors by multiple criteria (6) . With chronic caloric restriction of obese mice, as well as with acute starvation of obese and thin mice, the plasma insulin concentrations fall and receptor concentrations rise (3) . In both the fed and food-restricted states, the receptor concentration is inversely related to the level of circulating insulin.
The insulin receptors in obese humans are not as well characterized. With circulating mononuclear cells, we have previously shown that some obese patients have impaired binding of 1251-insulin and that chronic caloric restriction improves this defect in hormone binding (13) . The nature of the defect and the mechanism of this adaptation have not been clearly defined. These initial studies measured insulin binding to mixed mononuclear leukocyte preparations derived from Ficoll-Hypaque gradients (13, 14) . We have re- cently demonstrated that monocytes, which constitute about 20%o of this mixed cell population, account for 85-90% of the insulin binding (15) . Therefore, changes in monocyte number could result in major alterations in insulin binding. In an attempt to clarify the mechanisms ofinsulin resistance in human obesity, we have examined insulin binding to circulating monocytes of obese patients under various dietary conditions including the basal, fed state, after h of starvation, after refeeding, and finally after chronic diet.
METHODS

Patients
A. Obese patients. Seven obese patients (A.-G.), selected to represent the range of carbohydrate metabolic defects seen in obesity, were studied while inpatients in the Clinical Center of the National Institutes of Health (Fig. 1 , Table I ). They were taking no medications and were free of disease except for patient E. who had congenital alkalosis and has previously been reported (16) . In patient E. all metabolic and hormone binding studies were done after hypokalemia and alkalosis had been corrected.
Patients were initially maintained on a 3,500 calorie, weight-maintaining diet (=45% carbohydrate, 20% protein, and 35% fat) for periods of 3-7 days. Oral glucose tolerance tests with 100 g of glucose and one to three insulin binding studies were done in this basal, fed state. Patient A. was further tested after a 72-h fast. The four patients demonstrating lowest basal insulin binding (B.-E.) were selected for detailed study. After basal studies were completed, these four patients were fasted (<50 calories per day = "acute fast") with insulin binding studies performed after 24, 48, and 72 h of fast (the designated time intervals are in addition to the initial 10 h overnight fasting period). Upon completion of the 72-h fast the 3,500 calorie diet was reinstituted ("refeeding") with repeat binding studies performed after 2-10 days. Patients were then begun on a 600 calorie diet (45% carbohydrate, 20% protein, 35% fat) for 6-12 wk ("chronic diet"). Plasma glucose and insulin levels were measured after overnight fasting on days that insulin binding studies were performed.
B. Normal volunteers. 10 normal volunteers, 7 males and 3 females, aged 18-32 yr were studied while inpatients. All were within 10% of their ideal body weight, had fasting plasma insulin concentrations of 5-18 ,uU/ml, and showed normal plasma glucose and insulin responses after ingesting '25I-insulin binding study. Whole blood was drawn into acid-dextrose-citrate solution (Fenwal plasmapheresis triple blood pack Fenwal Inc., Walter Kidde and Co., Inc., Ashland, Maine) and centrifuged. The erythrocytes and plasma were returned to the patient. The buffy coat was diluted 1:1 with phosphate buffered saline (pH 7.4), layered onto Ficoll-Hypaque gradients, and centrifuged according to the method of Boyum (17) . The mononuclear cell layer was removed and diluted in 100 mM HEPES buffer (pH 8) to a final concentration of 50 x 106 mononuclear cells per ml. Viability, as assessed by trypan blue exclusion, was always greater than 98%. The percentage of monocytes in this final mononuclear preparation was determined by phagocytosis of latex beads (18) and verified by esterase staining of monocytes (19) . Good agreement was found between these two methods, with esterase staining giving results -10% higher than found with latex bead ingestion.' There was no systematic difference in monocyte content in mononuclear cell preparations of the obese or normal subjects (Table II) .
125I-insulin was prepared at a specific activity of 150-200 ,uCi/,g insulin (=0.5 I per insulin) as previously described (20) (21) (22) . 1251-insulin, 0.2 ng/ml, was incubated with 40 x 106 mononuclear cells per ml in the absence or presence or unlabeled insulin over a range of insulin concentrations from 0.2 through 100,000 ng/ml with final incubation volume of 0.5 ml per assay tube. In this study the assay buffer was 100 mM I The monocyte count actually used for calculation of binding data was determined by latex bead ingestion. ng/mI) was inctubated with 40 x 106 mononuclear cells/ml in the absence or presence of unlabeled insulin over a range of instulin concentrations from 0.2 to 100,000 ng/ml. After 180 min at 22°C, replicate 0.2-ml-aliquots of the assay mixture were transferred to microfuge ttubes, centrifluged, and the supernatant fluid was aspirated. The tips of the tubes containing the pellet were excised and counted. Nonspecific binding, defined as the radioactivity in the cell pellet in the presenice of 105 ng/ml insulin, was subtracted from the total binding at each instulin concentration and(l normalized to a monocyte concentration of 107 cells/ml. Each point is the meani of replicate samples. The shaded area represenits the mean+ 1 SD of 17 instulin binding sttudies performed in 10 nornilal vol uinteers.
HEPES, pH 8.0, and the assay tubes were incubated for 180 min at 22°C. These assay conditions produce a steadystate binding with less than 10% degradation of labeled hormone, no receptor degradation, and pH change of less than 0.15 pH U during the 180-min incubation. 1251-insulin binding with these modified conditions was also consistently greater than previously found.2 After 180 min of incubation replicate 0.2-ml-aliquots of the incubation mixture were transferred to microfuge tubes and centrifuged. The supemate was aspirated and the cell pellet contained in the tip of the microfuge tube was excised and the radioactivity counted. Under these conditions nonspecific binding, defined as the amount of 1251_ insulin bound to the cell pellet in the presence of 105 ng/ml insulin, was 0.3-0.7% ofthe total radioactivity for both normal and obese patients and was subtracted from total binding to give specific binding. 1251-insulin specifically bound was then expressed as a function of monocyte concentration. The methodology of this stuidy introdtuces modest clhanges in the preparation of the cells aind several changes in the condition of the 125I-insulin binding assay including pH, temperattire, aind buffer composition.3 Wve halve also nor-2 Manuscript in preparation. 3 Previous reports from this laboratorv performed binding studies with Tris buffer (25 mM, pH 7.6) and a 90-min incubation period at 15°C. malized the data to correct fb)r the vairiationis in monocvte content (15) . With the improved methodology, wve noow findl tlht the total bindin-g of '25I-insu1in to the cells of the niorml-sll subjects is in ac narrower range aind slightly lhigler than previouisly reported (13, 14) . The nonispecific binding aniid tle concentration of hormonie that reduced the binding of 1']insulin by half, both of which had beenl higlher with tle cells of the obese (13, 14) , were nlow the samiie for the obese andl thin adults and lower than previously rel)orted. Miore importantly, the improved precision of the datal as wvell ats a greater appreciationi of the complexities of tlhe initeractionl of insulin with its receptor, halve permitte(d a iore dletaile(d analysis of the insulin binding. Data analysis. The data on binding of '25j-in.stulinl to r-eceptor is presented in three ways whichl emplhasize differenlt quantitative aspects of the bindinig interaction. (1) The percent of total radioactivity that is specifically bound to receptors is plotted as a fuinction of log total] insulinl conicentration; this most closely represenits the actual experimental results. (2) Bound/free of '25I-instulin, (B/F)4 is plotted as a function of bound (B) hormiionie (Scatelhard plot) (23) . For insulin biniding to its receptors this llot is curvilinieatlr.
4Abbreviatiotns used in this papeer: B/F, hound/free; K, affinity; R, limiting high affinity state; Kf, limiting low affinity state; Ro, total concentration of receptor sites per cell. . a
Scatchlard analyses of l25I-insulin binding to monocytes of obese patients A.-G. and normal volunteers. The ordinate, B/F, is the ratio of bound to free lhormone and the abscissa represents the insulin bound (ng/ml), both expressed per 107 monocytes per ml. For each patient maximal B/F and the intercept at the abscissa are designated by arrowvs. The two shaded areas represent the range of normal for maximal B/F and abscissa-intercepts, respectively. The inset is an enlargement of the portion of the graph enclosed by the rectangle.
The total binding capacity or total concentration of receptor sites (RO) is derived from the point '%'here the linear extrapolation of the cutrve intersects the horizontal axis. (3) The third method of data analysis is the "average affinity profile". Because the insulin receptor sites are not independent of one another, traditional methods for deriving the affinities of the receptors from curvilinear Scatchard plots are not valid (24) . Experimental data suggest that the insulin receptors are a single set ofhomogeneous binding sites that undergo negatively cooperative site-site interactions such that the affinitv of the receptors for insulin is inversely related to the fractional occupancy (25, 26) . The average affinity profile expresses the relationship between the average affinity for insulin (k) and receptor occupancy (Y) (27) . At anx' point i on the Scatchard curve, the average affinity = K1 = (B/F)1 where B1 = the concentration of bound hormone Ro-B, and (B/F)i = the bound/free hormone at that point (for details of this analysis see reference 27). When the affinity (K) is graphed versus log of the fractional occupancv of the receptor (Y' or B/RB) the plot displays the average affinity of the receptor at all levels of receptor occupancy and is referred to as the "average affinity profile" (27) . In this analysis, the limiting high affinity state, obtained at lowv levels of receptor occupancy, is designated k,; the limiting low affinity state, obtained at high levels of receptor occupancy, is Kf. In this paper, xve have designated K, as the value of K wlven the 125I5-insuliin concentration is 0.2 ng/ml. 5 It should be noted that the validity of this analysis (and of the derived parameters) does not depend on assigning a particular model to the molecular mechanisms involved in the cooperativity (27) .
RESULTS
I. Basal 1251-insulin Binding in Normal and Obese
A. Normiial volutnteers. 17 instulin sttudies were performed in 10 normal volunteers. At every insulin concentration insulin binding to monocytes fell within narrow limits (Fig. 2, shaded area) . When a given individual was studied on separate occasions variability of data was also small. When these binding data were analyzed by the mietlhod of Scatclhard, curvilinear plots were obtained. The instil in receptor conceintrationis on normiial cells ranged from 15,000 to 28,000 sites per cell witlh a mean of 22,000 sites per cell. The relationship between changing receptor affinity for lhormone and occtipanicy of receptor sites by the hormiionie is expressed by the average affinity profile. In miioniocytes from normal volunteers, the highest or "empty sites" affinity, Ke, ranges from 0.10 to 0.23 nM-1 and begins to decrease when only 0.3% of total receptor sites are occutpied. With increasing occupancy of receptors by hormone, apparent K progressively decreases uintil a Kf, is reached. In normal voluinteers Kf ranges between 0.02 and 0.04 nM-1 and is reached when only 10-20% of available receptor sites are occupied.
Fltuctutations in the Affinity and Concentration of Instulin Receptors
B. Obese. Studies of monocytes from the seven obese patients demonstrated a wide range of 1251_ insulin binding curves, consistent with the wide range of basal levels of circulating insulin seen in this obese group (Fig. 2) . Three patients were within +2 SD of normal while in the others binding was decreased by 40-70% as compared to normals. On Scatchard analysis the plots were all cturvilinear and rouighly parallel to one another and to the cturves from the normal stubjects ( Fig. 3 ). This suiggested tlht receptor affinities and niegative cooperativitv were largely uinialtere(d aniid tlait the ol)served reduictioni in '21I-instilin binding wats dute to a decrease in receptor concentration. The lack of clhange in receptor affinity was conifirmiied by the average affinitv profiles (Fig. 4 ). These plots slhowed that both ke and kf as well as the entire affinity profile in the obese were withiin the range of the normal suil)jects. Tlhuis the diminislhed basal binding of 1251-instlin to mnonocyte receptors ofobese patients was accouinted for by changes in receptor concentrationi withouit ainy significant alteration in receptor affinity.
II Effect of Acute Fast and Chronic Diet in Obese Patients
The fouir obese patients with the most impaired basal 125I-instl in binding (B., C., D., and E.) were futrtlher sttudied dturing periods ofactute fi:sting and after chronic diet. Witlh actute fuisting, elevated basal plasmia insutlin conicentrations fell (Table I) , body weiglht decreased l)v 2-3 kg, and turinary ketones became strongly positive in all patients. Dturing the period ofchronic diet restriction obese patients lost [13] [14] [15] [16] [17] [18] [19] kg of body weight aind patients B., C., aind D. lowered their plasma insulin to the normal range, while patient E. lowered his plasma insulin from 60 to 35 /iU/ml. Both types of diet (accute fast and chronic diet) resulted in normalization of binding of tracer concentrations of '251-insulin in all four patients; however, the mechanisms whereby these changes were effected clearly differed. To illustrate these phenomena a single patient, E., will first be considered in detail.
A. Obese patieWt E. In the basal state, obese patient E. lhad the most profouind depression of' 1251_ insulin binding with monocytes binding -30% as muchl insulin as normal ( Fig. 5 ). This decreased 1251-insulin binding was accompanied by a comparable decrease in Ro, i.e. -6,000 sites per monocyte basally compared to a normal mean of 22,000 sites per monocyte. When acutely fasted, patient E. had no changes in instlin binding at 24 h but at 48 and 72 h of fast increases in '251-instulin binding became evident (Fig. 5 ). This increased hormone binding was present only at relatively low, physiologic concentrations of instilin. Thus, at an insulin concentration of 0.2 ng/m] (5 ,uU/ml) there was a fivefold increase in 1251-insulin binding while at insulin concentrations greater than 1.0 ng/ml (25,uU/ml) no significant difference was seen between binding in the basal state and binding after a 72-h fast. The binding alterations with acute fasting were associated with little or no change in Ro (Fig. 5 ) but with a marked increase in k, the affinity of the "empty site" or high affinity state. Basally Ke was 1.2 x 108 (M-') and with acute fasting increased to 6.0 x 108 (M-1), while Kf (0.04 nM-1) and Ro remained constant. Binding-competition curves are determined by the methods described in Fig. 2 . Scatchard analyses and average affinity profiles are calculated as described in Analysis of Data. For Scatchard analyses, the shaded area is defined by the two normal volunteers with highest and lowest RO; for the average affinity profiles the shaded area is defined by plots of the two normal volunteers with highest and lowest Ke* Chronic diet also produced increases in 1251-insulin binding (Fig. 5 ). In this case, however, the binding increase was apparent at all hormone concentrations and Scatchard plots demonstrated that this was due to an increase in Ro from 6,000 sites per cell basally to 22,000 sites per cell after chronic diet. This increase in Ro was not accompanied by any change in affinity ( Fig. 5) . Therefore, the restoration of insulin binding to normal by the chronic diet was solely caused by an increase in receptor concentration. B. Obese Patients B., C., and D. During acute fasting, patients B., C., and D. showed binding changes similar to those of patient E. (Fig. 6 ). In these patients after 72 h of fasting 1251-insulin binding was increased to normal levels but the increase was only found at insulin concentrations less than 5 ng/ml (100 lU/ml). Scatchard plots and average affinity profiles of these data revealed that the increased binding was associated with little change in R& but with markedly increased Ke. At higher concentrations of hormone, the affinity differences between acute fast and basal study became less pronounced, so that when more than 7-10% of total receptor sites were filled, the affinity curve with acute fasting became indistinguishable from the affinity curve derived from basal data. The binding competition curves shown were determined by the method described in Fig. 2 . The shaded area represents the mean±1 SD of 17 1251-insulin binding curves in 10 nornal volunteers.
glucose and insulin concentrations, and insulin binding returned to basal, fed state levels (Table I, Fig. 6 ). The binding changes induced by refeeding were due entirely to a reduction of Ki to the level observed in the basal state. Chronic diet, which was associated with a fall in plasma insulin concentrations to normal levels, also resulted in normalization of 1251.insulin binding in patients B.-D. As with patient E., chronic diet was associated with an increase in Ro to normal while all parameters of affinity were unchanged and well within the normal range.
C. Patient A. Patient A. was an obese patient with normal basal 125I-insulin binding to her circulating monocytes (Fig. 6 ). Although equally obese (207% of ideal body weight), her basal plasma insulin concentration was the lowest of the obese group (Table I) . Further, this patient had normal plasma glucose and insulin responses to oral glucose challenge (Fig. 1) .
After 72 h of fasting her insulin binding did not sig- nificantly change ( Fig. 6 ) and no change in R0 or K.3 was detected during the acute fast. Similar results were obtained when four normal volunteers were fasted for 48 or 72 h (data not shown).
III. Summary and relationship of Ro to circulating plasma insulin concentrations
The effects of acute fast, refeeding, and chronic diet on insulin binding parameters in patients B.-E. are summarized in Fig. 7 . In the basal, fed state patients B.-E. have decreased 1251-insulin binding, reduced R, but normal kR suggesting the presence of decreased numbers of normal receptors accounting for the diminished insulin binding by these monocytes. With acute fasting insulin binding increased to normal (B., C., and D.) or supranormal (E.) levels with little change in H and 1.5 to 5-fold increase in k. Refeeding of a high calorie diet resulted in return of all binding and metabolic parameters to the basal state. With chronic diet, insulin binding, receptor number, and receptor affinity for hormone became indistinguishable from normal (Fig. 7) .
In the basal state, when plasma insulin concentration is plotted against receptor concentration (or initial B/F), an inverse relationship is found (Fig. 8A) , i.e., the higher the patient's plasma insulin concentration the lower the R. This inverse relationship between R0 and circulating insulin concentration was also found during the refeeding stage and with chronic diet (Fig. 8B) ; however, after acute fasting R0 was essentially unchanged despite significant falls in plasma insulin concentrations (Fig. 8B ).
DISCUSS ION
Clinical states of hormone resistance can be due to an impairment in the delivery ofthe hormone to the target cell (for example, antihormone antibodies) or to defects at the target cell itself. At the target cell, the defect can be in the first step, the binding of the hormone to its receptor, or at any one of the multitude of steps between binding to receptor and the final effects of the hormone. Of the many conditions characterized by hormone resistance, the insulin resistance of obesity is the most common and best studied. In obese mice, insulin resistance is associated with a decreased concentration of insulin receptors (3) (4) (5) (6) . This decrease in insulin receptor concentration is reversible since receptor concentration can be restored toward normal by both acute fasting and chronic dieting (3).
To study the insulin receptors of obese humans under dietary conditions similar to those in the obese rodents, we should ideally study the insulin receptors of the liver, since the function of that organ is the overwhelming determinant of glucose homeostasis in * -- Fturtlhermiore, in patients xvith the syndromes of' instulin resistanice associated 'with acanitlhosis nigricanis, the degree of impairmilenit of bindinag of '25I-instulin to the circuilating monocytes of these paitienits correlated very closelv \vith the severity of' tle inisuilin resistanice observed clinically (29, 30) . Thuts, we consider that the specific instulini binding sites of lhtumlani monocvtes are representative of the state of inistuilin receptors in liver and other tisstues throuiglhotut the body.
In the presenit study, wve have confirmed the finding that hvperinsulinemic obese patients have decreased insuilini bindinig (13, 14) and we nowN find that the decrease in instulin binding is duie entirel to a decrease in the concenitration of instulini receptors. In these hvperinstulinielmiic obese patienits chronic diet lowered circtulating inistulin levels anid retturnied insutlinl binding and receptor concenitrationis to normiial. In the basal (fed) and chronically dieted states, the total receptor concentrationi oni the cells of' the obese patienits was inversely related to the restinig levels of circtulating instulin. Thuts, obese people aind obese miiice have quiite simiilar defects in insuilini binding in the fed state and respond identically to chlonic dietinig. In addition to the previous repolts firomi ouir labora- tory (13, 14) , tlhree other grouips haiive evaluiated the statuis of instulin receptors in lhtumani obesity. Malrinetti et al, in a preliminilary stuidy with fat cell membranes from obese people, was the first to stuggest that insutlini binding was decreased in obesity (10) . In at detailed sttudy of obese patients, Amatrtuda and his co-workers reported that, when expressed on a peri cell basis, ft't cells from obese patients bouind inlsulin as well as did cells from normal sulbjects (31) . However, if these data are expressed per adipocvte suirfcfee aireat rather than per whole cell, the obese patients in Amiatruda's study then show a receptor concentration decrease comparable to that of' ouir patients.63 In cl recenit sttudy (32) , Olefsky fotund that the conicentration of insuilin receptors on f'at cells of obese patients is decreased whether expressed per cell or-per uinit of cell sturface althouigh clearly the defect is more marked when expressed per uinit of cell stirf'ace. He also fouindl 6 Fat cell size is known to increase in the obese state, consistent with the data from Amatruda's study in which the diameter and surface area of the fat cells from the obese patients were 1.6 and 2.5 times greater, respectively, than those in the normal subjects. The present sttudies add stupport to the idea that one of the major infltuences on the receptor concentration is the chronic level of insulin to which the cells are being exposed (3, 33) . We show that in obese patients uinder basal conditions, the concentration of insulin receptors is inversely related to the resting level of circulating instulin, and in obese patients who are not hyperinstulinemic or insulin resistant, receptor concentrations are normal. Chronic dieting of these hyperinstulinemic obese patients is accompanied by a fall in the ambient insulin and a commensurate rise in the receptor concentration. In thin hyperinstl inemic diabetics and in hyperinsulinemic obese patients, Olefsky and Olefsky and Reaven demonstrated that the concentration of insulin receptors on circulating monocytes is decreased (32, 34) . Correlations between the ambient insulin concentration and the receptor concentration are even more extensive in mice. In both obese and thin mice studied in the fed, fasted and dieted states, there is an excellent correlation between circulating levels of insulin and the receptor concentration. When obese mice are fasted for 24 h, plasma insulin levels fall and receptor concentrations increase (3) . Treatment ofthe mice during the fast with repeated doses of insulin prevents the restoration of the receptor concentration. Streptozotocin treatment of obese mice also corrects the hyperinsulinemia, and elevates receptor concentrations (35) . Additionally, diabetic Chinese hamsters, who have abnormally low levels of insulin in both plasma and pancreas, have elevated concentrations of insulin receptors in plasma membranes of liver (36) . The effect of insulin on the concentration of its own receptors is direct and can be reprodtuced in vitro by incubating cultured htuman lymphocytes (IM-9 line) in the presence of insulin (33, 37 ). When exposed to insulin these cells show a decrease in the concentration of insulin receptors; the speed and magnitude of the fall in the insulin receptor concentration is dependent on the concentration of insulin in the medium (33, 37, Fig. 9 ). Recent sttudies employing insulin analogtues and inhibitors of protein synthesis fuirther MOLES/LITER 10-8 10-6 10 100 1000 10,000 AMBIENT INSULIN CONCENTRATION (ng/ml) FIGURE 9 Effect of ambient insulin concentration on insulin Ro in human monocytes, mouse liver cell plasma membranes, and in cultured human lymphocytes. For the human monocytes and mouse liver membranes, the insulin concentration is the basal level of plasma insulin in vivo measured by radioimmunoassay with porcine insulin and mouse insulin standards, respectively; the receptor concentration is expressed as percent of normal volunteers (mean) for human studies and percent of thin littermates for the obese mice. The cultured human lymphocytes were preincubated with the designated insulin concentrations for 18 h, then washed extensively before binding studies were performed. For the cultured lymphocytes, 100% receptor concentration represents the R& when cells were preincubated with culture medium alone.
Data for the obese mice and cultured lymphocytes are found in references 3, 33, and 37. indicate that the effect of instulini on the concentration of its own receptors is at direct regulatory process effected at the target cell via the instlin receptor itself (37) .
Fluctuations in the Affinity and Concentration of Insulin Receptors
The insulin receptors on hulmiani monocytes appear more sensitive to the effects of chronic elevations in ambient instulin than either mice in vivo or culttured hutman lymplhocytes in vitro ( Fig. 9 ). For hulmians a 50% decrease in receptor conicentration was found with circulating levels of :2 ng/mI (50 ,uU/ml), while in mice, a comiiparable 50% decrease in receptor concentration required ambient inisulin conicentrations of 30 ng/ml ( Fig. 9 ). This is consistenit witlh the observations that, in general, rodents in vivo are less sensitive to insulin than are humans. The IM-9 lymphocytes are even more resistant; 400 ng/ml of insulin is needed to reduce receptor concentrations by 50%. Further studies will be required to determine if this reduced sensitivity is a general clharacteristic of lymphocvtes in ctultture or varies froim cell line to cell line.
The receptor affinity chaniges associated with acuite fasting of hyperinsulinemic obese patients represent a uiniquie finding of our stuidy. Wlihen obese mice were actutely fassted, receptor concenitrations increased while clhanges in receptor affinity were not observed (3) . The affinity clhaniges seen in the hyvperinstl inemic obese hutmians were ratlher specific sinice thev were not observed when tlhin normals andcl obese patients with minimal hyperinstulinemia were similarly fasted. This change in affinity would have the effect in vivo of normalizing instlin binding at low resting levels of circulating inssulin while mainitaining the relatively impaired binding at stimuclated levels of' hormone. The molectular mediators of these affinity changes are tinknown. It is uinlikely that the ambient instlin level directly effected these affinity changes since the plasma instlin levels were similar with actute fast and chronic diet vet no change in receptor affinity was seen with clhronic diet. It should be pointed ouit that there are other examples where the affinity of the receptor for insulin can be regulated widely under biologically relevant conditions. Occuipancy of only a small minority of the receptor binding sites by instlin produces a marked fall in the affinity of all of the receptors becatuse of negatively cooperative site-site interactions among the receptors (25, 26) . Fluctuations in pH within the range observed in vivo also produce major changes in receptor affinity. Conceivably, one or more small molecules, possibly metabolic intermediates, may act in vivo to regtlate the affinity and cooperativity of the insulin receptor, analogouis to the role of 2,3 diphosphoglycerate in regulating the binding and dissociation of oxygen and hemoglobin. It is important to emphasize that receptor concentration, as well as receptor affinity, are probably stubject to nuimerouis other potential influiences, including the effects of other hormones, dietary composition, age, metabolic alterations suich as acidosis or ketosis, as well as stages of growth, development, and differentiation. In addition, observations here and elsewhere of significant changes in plasma insulin levels without concomitant changes in receptor concentrations (as well as the converse) should serve to emphasize that the ambient insulin concentration is buit one of the many influiences on the receptor (38) (39) (40) .
In stummary, we have demonstrated that an insulin receptor undergoes changes in both its affinity and concentration in vivo. By coordinating changes in receptor affinity and receptor concentration with other regtulatory events within the cell, the target cell is thereby capable of a broad range of responses to hormonal stimtuli.
